It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive ...

Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal ...

More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the ...

Fact checked by Nick Blackmer The Biden Administration proposed a new rule that would require Medicare and Medicaid to cover ...

The rise in obesity rates across the United States has brought increased attention to treatments aimed at addressing the ...

The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...

The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

U.S. President Joe Biden on Tuesday proposed expanding coverage of anti-obesity drugs, like Novo Nordisk's Wegovy, for more ...

Medicare coverage would reduce out-of-pocket costs for AOMs – which can currently be as high as $1,000 a month - by as much ...

The Biden administration proposed a new rule Tuesday that would allow anti-obesity drugs like Wegovy and Zepbound to be ...